Treatment of shock following myocardial infarction.
D001285:Atropine / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008680:Metaraminol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications*; D009638:Norepinephrine / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000008:administration & dosage; D012769:Shock / Q000209:etiology* / Q000628:therapy
D002301:Cardiac Glycosides; D010952:Plasma Substitutes; D001285:Atropine; D005665:Furosemide; D008680:Metaraminol; D007545:Isoproterenol; D009638:Norepinephrine